Tricyclic PGD2 Methyl Ester Synthesis with Fewer Steps and Higher Yield

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for synthesizing tricyclic prostaglandin D2 metabolite methyl ester are complex and inefficient, requiring numerous steps and low overall yields, limiting their availability for clinical assays.

Innovation Solution

A concise synthesis method involving transition metal-catalyzed transformations, including nickel-catalyzed dicarbofunctionalization, palladium-catalyzed carbonylative spirolactonization, and Z-selective cross metathesis, to efficiently produce tricyclic prostaglandin D2 metabolite methyl ester from readily available starting materials.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional synthesis methods are used, then the synthesis can be performed with existing procedures, but the number of steps is large and overall yield is low

Engineering Contradiction:
Improveoverall yieldVSAvoidnumber of synthesis steps
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The synthesis is divided into distinct modular stages: (1) formation of iodo-acetal intermediate, (2) nickel-catalyzed cyclization to form cyclopropanol, (3) oxidation to lactone, and (4) Z-selective cross metathesis. Each stage can be optimized independently, reducing the cumulative impact of step-wise yield losses while maintaining manageable complexity at each step.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The iodo-acetal intermediate is prepared in advance with the correct stereochemistry and functional groups pre-positioned. This preliminary structuring allows the subsequent nickel-catalyzed cyclization to proceed efficiently in a single step, avoiding the need for multiple sequential transformations that would increase overall step count and reduce yield.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If multi-step synthesis procedures are used, then the synthesis can achieve the target molecule, but the time required for synthesis is excessive

Engineering Contradiction:
Improvesynthesis speedVSAvoidtotal synthesis time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The synthesis employs continuous flow conditions in the nickel-catalyzed cyclization step, where reactants are continuously fed through the catalytic system. This eliminates batch processing downtime and allows the reaction to proceed without interruption, significantly reducing the time required for this critical transformation step while maintaining high conversion and selectivity.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The reaction conditions are optimized by changing key parameters: using specific ligands on the nickel catalyst, controlling temperature and pressure conditions, and adjusting solvent composition. These parameter optimizations enable faster reaction rates without sacrificing selectivity, thereby reducing the time required for each synthesis step while maintaining high overall efficiency.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If traditional cyclization methods are used, then the reaction can proceed with conventional reagents, but the yield of cyclization product is low

Engineering Contradiction:
Improvecyclization yieldVSAvoidease of cyclization
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

A nickel catalyst with specific ligands serves as an intermediary that mediates the cyclization reaction between the iodo-acetal and ester functional groups. This catalytic intermediary lowers the activation energy barrier for C-C bond formation, enabling the cyclization to proceed with high yield under mild conditions that are easy to implement and scale.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The traditional acid- or base-promoted cyclization mechanisms are replaced with a transition metal-catalyzed cross-coupling mechanism. This substitution enables the reaction to proceed through a different pathway that avoids harsh conditions and side reactions, achieving higher yields with better selectivity and easier product isolation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Manufacturing precision

If conventional metathesis catalysts are used, then the reaction can be performed with standard conditions, but Z-selectivity is insufficient

Engineering Contradiction:
ImproveZ-selectivityVSAvoidease of metathesis reaction
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The metathesis catalyst is designed with specific local structural features: a ruthenium center coordinated with a particular ligand architecture that creates a chiral environment. This local structural quality at the catalytic site enables preferential formation of the Z-isomer through steric and electronic control during the metathesis transition state, achieving high Z-selectivity while maintaining catalytic activity under practical conditions.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high yields of up to 75 mg of tricyclic prostaglandin D2 metabolite methyl ester, providing sufficient material for clinical assays and overcoming the limitations of previous synthesis methods.

Implementation Method 1

nickel-catalyzed dicarbofunctionalization

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

palladium-catalyzed carbonylative spirolactonization

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 3

Z-selective cross metathesis

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS12466791B2Methods for synthesis of the tricyclic prostaglandin D<sub>2 </sub>metabolite methyl ester
Publication Date: 2025.11.11 PURDUE RES FOUND
  • US12466791B2 patent drawing
  • US12466791B2 patent drawing
  • US12466791B2 patent drawing

AI summary

Methods for the synthesis of a tricyclic-prostaglandin D2 metabolite methyl ester or a pharmaceutically acceptable salt thereof.